VolitionRX Q2 EPS $(0.08) Beats $(0.09) Estimate, Sales $395.80K Miss $480.00K Estimate
VolitionRX Q2 EPS $(0.08) Beats $(0.09) Estimate, Sales $395.80K Miss $480.00K Estimate
volitionrx第二季度每股收益为$(0.08)，超过预期$(0.09)，销售额为39.58万美元，低于预期48万美元。
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 11.11 percent. This is a 42.86 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $395.80 thousand which missed the analyst consensus estimate of $480.00 thousand by 17.54 percent. This is a 82.98 percent increase over sales of $216.31 thousand the same period last year.
VolitionRX(美交所：VNRX)报告每股亏损$(0.08)，超过分析师共识预期$(0.09)的11.11%。这相比去年同期每股亏损$(0.14)增加了42.86%。该公司报告的季度销售额为$39.58万，较分析师的预期$48万低17.54%。这是去年同期销售额$21.631万的82.98%增长。
资讯热榜
更新时间